Skip to content
Evigrade
CriticalMacrolide antibiotic×Selective If channel inhibitor of the sinoatrial node

Updated · Methodology

Mechanism

In the liver and gut, only the enzyme CYP3A4 breaks down ivabradine, so inhibitors of this enzyme raise its blood levels. High ivabradine levels can cause excessive slowing of the heart rate (ivabradine summary of product characteristics, SmPC, European Medicines Agency, EMA). Erythromycin inhibits CYP3A4 and the transporter P-glycoprotein. The Spanish erythromycin SmPC calls it a moderate inhibitor, while the European ivabradine SmPC lists oral erythromycin together with strong CYP3A4 inhibitors such as ketoconazole and clarithromycin (erythromycin SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; ivabradine SmPC, EMA). The documents do not say how much erythromycin raises ivabradine levels. The second mechanism involves the QT interval. QT prolongation with a risk of torsade de pointes has been observed during erythromycin treatment, and the slower heart rate caused by ivabradine can worsen QT prolongation (erythromycin SmPC, AEMPS, and ivabradine SmPC, EMA).

Symptoms

Excess ivabradine causes severe and prolonged slowing of the heart rate: a resting heart rate below 50 beats per minute, dizziness, fatigue and low blood pressure (ivabradine summary of product characteristics, SmPC, European Medicines Agency, EMA). Sinus arrest and heart block have also occurred during ivabradine treatment (ivabradine label, US Food and Drug Administration, FDA). QT prolongation itself causes no symptoms and shows only on an electrocardiogram (ECG), while an arrhythmia causes palpitations, dizziness and fainting. Deaths from arrhythmia have been reported in people treated with macrolides, including erythromycin (erythromycin SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The risk is higher with a slow heart rate, low potassium or magnesium, and other QT-prolonging drugs (erythromycin SmPC, AEMPS, and ivabradine FDA label).

Management

The combination with oral erythromycin is contraindicated. The European ivabradine summary of product characteristics (SmPC) lists oral erythromycin among the strong inhibitors of the enzyme CYP3A4 that must not be taken with ivabradine (ivabradine SmPC, European Medicines Agency, EMA). The same SmPC lists intravenous erythromycin among drugs that prolong the QT interval. Avoid this combination. If it cannot be avoided, careful cardiac monitoring is needed (ivabradine SmPC, EMA). The US ivabradine label contraindicates strong CYP3A4 inhibitors and says to avoid moderate ones, and the Spanish erythromycin SmPC classes erythromycin as a moderate inhibitor (ivabradine label, US Food and Drug Administration, FDA; erythromycin SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). So, during a course of oral erythromycin, choose another antibiotic or pause ivabradine (this follows from the contraindication). Clarithromycin, josamycin and telithromycin are also contraindicated with ivabradine, and the SmPC says to avoid QT-prolonging drugs with it (ivabradine SmPC, EMA). Erythromycin itself is contraindicated with a history of QT prolongation or ventricular arrhythmia and with low potassium or magnesium, and its SmPC advises caution in clinically significant bradycardia (erythromycin SmPC, AEMPS). The US label says to avoid erythromycin in that case (erythromycin FDA label). If the drugs have already been taken together, stop one of them (this follows from the contraindication) and monitor the heart rate and electrocardiogram (ECG). With a resting heart rate below 50 beats per minute or symptoms of bradycardia, reduce the ivabradine dose, and if bradycardia persists, stop ivabradine (ivabradine SmPC, EMA). Treat severe bradycardia in a specialised setting: if it is poorly tolerated, consider intravenous beta-stimulants such as isoprenaline and, if needed, temporary cardiac pacing (ivabradine SmPC, EMA). The documents give no interval for restarting ivabradine after erythromycin. Before restarting, measure the resting heart rate several times by ECG or 24-hour monitoring, and do not start ivabradine if it is below 70 beats per minute (ivabradine SmPC, EMA).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Erythromycin

Other interactions with Ivabradine